Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-033879
Filing Date
2025-11-07
Accepted
2025-11-07 16:47:12
Documents
61
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q crvo20250930_10q.htm   iXBRL 10-Q 1156359
2 EXHIBIT 10.1 ex_884815.htm EX-10.1 56699
3 EXHIBIT 31.1 ex_885015.htm EX-31.1 9879
4 EXHIBIT 31.2 ex_885016.htm EX-31.2 10300
5 EXHIBIT 32.1 ex_885017.htm EX-32.1 6782
6 EXHIBIT 32.2 ex_885018.htm EX-32.2 6687
12 cervologo.jpg GRAPHIC 25228
13 logosm.jpg GRAPHIC 10403
  Complete submission text file 0001437749-25-033879.txt   5633893

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA crvo-20250930.xsd EX-101.SCH 45816
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20250930_def.xml EX-101.DEF 309711
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20250930_lab.xml EX-101.LAB 281084
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20250930_pre.xml EX-101.PRE 336043
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crvo-20250930_cal.xml EX-101.CAL 25720
64 EXTRACTED XBRL INSTANCE DOCUMENT crvo20250930_10q_htm.xml XML 904784
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 251463327
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)